Comprehensive metabolomics expands precision medicine for triple-negative breast cancer.
Cell Res. 2022 May;32(5):477-490. doi: 10.1038/s41422-022-00614-0. Epub 2022 Feb 1.
Cell Res. 2022.
PMID: 35105939
Free PMC article.